Ischaemic heart disease (IHD) and its consequences are major underlying pathogenic factors of heart failure and contribute significantly to morbidity and mortality worldwide. 1 Elective percutaneous coronary intervention has revolutionized the outcome after acute myocardial infarction (MI) resulting in a remarkable decrease in inhospital heart failure. 2 On the contrary, insufficient reestablishment of blood flow and late or unsuccessful reperfusion drive cardiomyocyte death, ventricular remodelling and increase in late heart failure